These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21412902)

  • 1. Chemotherapy wafers for high grade glioma.
    Hart MG; Grant R; Garside R; Rogers G; Somerville M; Stein K
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD007294. PubMed ID: 21412902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic wafers for High Grade Glioma.
    Hart MG; Grant R; Garside R; Rogers G; Somerville M; Stein K
    Cochrane Database Syst Rev; 2008 Jul; (3):CD007294. PubMed ID: 18646178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide for high grade glioma.
    Hart MG; Garside R; Rogers G; Stein K; Grant R
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007415. PubMed ID: 23633341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis.
    Xing WK; Shao C; Qi ZY; Yang C; Wang Z
    Drug Des Devel Ther; 2015; 9():3341-8. PubMed ID: 26170620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
    Ashby LS; Smith KA; Stea B
    World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
    Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide for high grade glioma.
    Hart MG; Grant R; Garside R; Rogers G; Somerville M; Stein K
    Cochrane Database Syst Rev; 2008 Oct; (4):CD007415. PubMed ID: 18843749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
    Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
    Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of the NICE Technology Appraisal 121 (gliadel and temozolomide) on survival in high-grade glioma.
    Barr JG; Grundy PL
    Br J Neurosurg; 2012 Dec; 26(6):818-22. PubMed ID: 22715955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image guided surgery for the resection of brain tumours.
    Barone DG; Lawrie TA; Hart MG
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009685. PubMed ID: 24474579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
    Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
    No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic therapy for high-grade glioma.
    Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.
    Kleinberg LR; Weingart J; Burger P; Carson K; Grossman SA; Li K; Olivi A; Wharam MD; Brem H
    Cancer Invest; 2004; 22(1):1-9. PubMed ID: 15069758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.
    Chowdhary SA; Ryken T; Newton HB
    J Neurooncol; 2015 Apr; 122(2):367-82. PubMed ID: 25630625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative imaging technology to maximise extent of resection for glioma.
    Jenkinson MD; Barone DG; Bryant A; Vale L; Bulbeck H; Lawrie TA; Hart MG; Watts C
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012788. PubMed ID: 29355914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter phase I/II study of the BCNU implant (Gliadel(®) Wafer) for Japanese patients with malignant gliomas.
    Aoki T; Nishikawa R; Sugiyama K; Nonoguchi N; Kawabata N; Mishima K; Adachi J; Kurisu K; Yamasaki F; Tominaga T; Kumabe T; Ueki K; Higuchi F; Yamamoto T; Ishikawa E; Takeshima H; Yamashita S; Arita K; Hirano H; Yamada S; Matsutani M;
    Neurol Med Chir (Tokyo); 2014; 54(4):290-301. PubMed ID: 24739422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Gliadel wafers in the treatment of high-grade gliomas.
    Bregy A; Shah AH; Diaz MV; Pierce HE; Ames PL; Diaz D; Komotar RJ
    Expert Rev Anticancer Ther; 2013 Dec; 13(12):1453-61. PubMed ID: 24236823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilic meningitis triggered by implanted Gliadel wafers: case report.
    Saito K; Yamasaki K; Yokogami K; Ivanova A; Takeishi G; Sato Y; Takeshima H
    J Neurosurg; 2017 Jun; 126(6):1783-1787. PubMed ID: 27285546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.